These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 20440292)
21. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Herder C; Karakas M; Koenig W Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741 [TBL] [Abstract][Full Text] [Related]
22. From genome-wide association studies to functional genomics: new insights into cardiovascular disease. McPherson R Can J Cardiol; 2013 Jan; 29(1):23-9. PubMed ID: 23200092 [TBL] [Abstract][Full Text] [Related]
23. Biomarkers in cardiovascular diseases: how can the "-omics" revolution be applicable at the bedside. Introduction. Tang WH Prog Cardiovasc Dis; 2012; 55(1):1-2. PubMed ID: 22824104 [No Abstract] [Full Text] [Related]
24. [Polygenic risk prediction of common diseases: from epidemiology to clinical application]. Jansen PR; Broeders MJM; Cornel MC; Meijers-Heijboer H Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556493 [TBL] [Abstract][Full Text] [Related]
25. Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes. Larson MG; Atwood LD; Benjamin EJ; Cupples LA; D'Agostino RB; Fox CS; Govindaraju DR; Guo CY; Heard-Costa NL; Hwang SJ; Murabito JM; Newton-Cheh C; O'Donnell CJ; Seshadri S; Vasan RS; Wang TJ; Wolf PA; Levy D BMC Med Genet; 2007 Sep; 8 Suppl 1(Suppl 1):S5. PubMed ID: 17903304 [TBL] [Abstract][Full Text] [Related]
26. From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population. Fava C; Montagnana M; Guidi GC; Melander O Ann Med; 2012 Aug; 44(5):433-47. PubMed ID: 21623699 [TBL] [Abstract][Full Text] [Related]
27. Cardiac Troponin T and Troponin I in the General Population. Welsh P; Preiss D; Hayward C; Shah ASV; McAllister D; Briggs A; Boachie C; McConnachie A; Padmanabhan S; Welsh C; Woodward M; Campbell A; Porteous D; Mills NL; Sattar N Circulation; 2019 Jun; 139(24):2754-2764. PubMed ID: 31014085 [TBL] [Abstract][Full Text] [Related]
28. Genomic risk prediction of complex human disease and its clinical application. Abraham G; Inouye M Curr Opin Genet Dev; 2015 Aug; 33():10-6. PubMed ID: 26210231 [TBL] [Abstract][Full Text] [Related]
29. Genetic Architecture of the Cardiovascular Risk Proteome. Benson MD; Yang Q; Ngo D; Zhu Y; Shen D; Farrell LA; Sinha S; Keyes MJ; Vasan RS; Larson MG; Smith JG; Wang TJ; Gerszten RE Circulation; 2018 Mar; 137(11):1158-1172. PubMed ID: 29258991 [TBL] [Abstract][Full Text] [Related]
30. Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases. Zaiou M; Benachour H; Marteau JB; Visvikis-Siest S; Siest G Curr Pharm Des; 2009; 15(27):3193-206. PubMed ID: 19754391 [TBL] [Abstract][Full Text] [Related]